Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of Quetiapine SR and Divalproex Sodium ER [valproate semisodium] on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2020
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Valproate semisodium
- Indications Bipolar I disorders; Bipolar II disorders; Generalised anxiety disorder; Panic disorder
- Focus Therapeutic Use
- 28 May 2020 Status changed from active, no longer recruiting to completed.
- 15 Feb 2013 Results published in the Journal of Affective Disorders.
- 13 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.